---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-029336"
form_type: "8-K"
ticker: "MBRX"
cik: "0001659617"
company_name: "Moleculin Biotech, Inc."
filed_at: "2026-08-31T21:15:01+00:00"
generated_at: "2026-08-31T21:16:11.882717+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Moleculin Biotech posts investor presentation; no material financial or clinical details disclosed

## Summary
- Corporate presentation dated August 31, 2026 published on company website.
- No revenue, earnings, clinical trial outcomes, or guidance figures provided in filing text.
- Materiality low; presentation content not reproduced in the 8-K submission.
- Ticker MBRX; presentation furnished under Regulation FD.

## SEC filing metadata
- accession: 0001437749-26-029336
- form_type: 8-K
- ticker: MBRX
- cik: 0001659617
- company_name: Moleculin Biotech, Inc.
- filed_at: 2026-08-31T21:15:01+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1659617/000143774926029336/0001437749-26-029336-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1659617/000143774926029336/mbrx20260818_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-029336
- JSON: https://secwatch.observer/filing/0001437749-26-029336.json
- Plain text: https://secwatch.observer/filing/0001437749-26-029336.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.